Did you Ride the Medplus Momentum?
September 4, 2024
On Sep 2, 2024, we had posted our analysis of a short-term uptrend in Medplus. Here is the chart we initially published
As anticipated by us, Medplus breached the 50%, 61.8% and 78.6% Fib levels in just 2 trading days.
From Rs. 685, the stock zoomed to Rs. 729, giving around 6.4% returns.
We alerted you right before Medplus took off.
Follow our Ideas to stay ahead of the game and find out stocks that will skyrocket soon!
Share the name of the stock you're interested in, and we'll be more than happy to conduct a thorough analysis for you.
Disclaimer: We are not SEBI registered. The content presented here is based on personal opinions. Conduct your own research and consult with a qualified financial advisor before making any investment decisions.
On Sep 2, 2024, we had posted our analysis of a short-term uptrend in Medplus. Here is the chart we initially published
As anticipated by us, Medplus breached the 50%, 61.8% and 78.6% Fib levels in just 2 trading days.
From Rs. 685, the stock zoomed to Rs. 729, giving around 6.4% returns.
We alerted you right before Medplus took off.
Follow our Ideas to stay ahead of the game and find out stocks that will skyrocket soon!
Share the name of the stock you're interested in, and we'll be more than happy to conduct a thorough analysis for you.
Disclaimer: We are not SEBI registered. The content presented here is based on personal opinions. Conduct your own research and consult with a qualified financial advisor before making any investment decisions.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.